INTRODUCTION

Multidrug-resistant
Acinetobacter baumannii (MDRAB) has emerged worldwide as a significant, commonly occurring nosocomial pathogen in health care facilities, primarily intensive care units (ICUs) (1, 2) . A. baumannii infections, which are often resistant to antimicrobial therapy, are a common cause of soft tissue infection, pneumonia, and bacteremia in debilitated patients and most commonly occur in ICU. Outbreaks of multidrug-resistant A. baumannii have been traced to common source contaminants, such as ventilator equipment, along with cross-infection from the hands of health care workers (1) . Risk factors for acquiring these isolates include patient conditions such as chronic pulmonary disease, and neurologic impairment, medical procedures such as intubation, insertion of central venous and urinary catheters and nasogastric tubes, and antimicrobial administration (1) (2) (3) (4) .
The definition of multidrug-resistant Acinetobacter spp. varies by country (1, 2) . In Japan, multidrugresistant Acinetobacter (MDRA) is defined as Acinetobacter spp. resistant to 3 specific antimicrobial classes: amikacin, carbapenem, and fluoroquinolone (5) .
The Clinical Laboratory Division of Japan Nosocomial Infections Surveillance (JANIS) program collected and provided the following data detailing the percentage of hospitals in Japan reporting antimicrobial susceptibility for the major species of clinical isolates: 0.2z of 5,477 hospitals with less than 200 beds, 25 .3z of 1,637 hospitals with 200 to 499 beds, and 57.1z of 415 hospitals with 500 or more beds in 2012 (6) . According to the 2012 JANIS clinical laboratory division annual report, Acinetobacter spp. was isolated from 20,997 patients, with only 0.8z of the Acinetobacter spp. isolates identified as MDRAB was isolated from as few as 4.4z of the hospitals JANIS assessed. Although nosocomial MDRAB outbreaks have been reported in Japan (7, 8) , the prevalence of MDRAB infection or colonization in Japan is much lower than in other countries (9) . Therefore, it is important to contain nosocomial outbreaks of MDRAB and maintain low prevalence rates of MDRAB infection and colonization in Japan.
Beginning March 2012, an outbreak of MDRAB in-fection and colonization was detected at a 500-bed tertiary critical care center (CCC) in the National Hospital Organization Mito Medical Center (NHO-MMC), located in the northeast region of the metropolitan area of Tokyo. The local public health center received the NHO-MMC report and conducted an outbreak investigation in collaboration with the National Institute of Infectious Diseases (NIID) on March 16, 2012 . This study involves the retrospective epidemiological investigation of the above MDRAB outbreak as well as the effectiveness of infection control measures employed to decrease its dissemination.
MATERIALS AND METHODS
Case definition and descriptive epidemiology: MDRA in Japan has been defined as Acinetobacter spp. resistance to 3 antimicrobials: amikacin, carbapenem, and fluoroquinolone (5 Epidemiological information, including demographic and risk factors such as medical procedures and antimicrobial administration, was collected from the medical charts of MDRAB cases during the study period. Environmental specimens from the CCC and other NHO-MMC areas were also collected and sent to the hospital laboratory for bacterial culture between March 12 and April 3, 2012. Japanese CCCs are officially defined as medical emergency facilities accepting severely ill patients 24 h a day through an emergency room (ER), containing more than 10 beds and an appropriate number of ICU beds.
Bacterial strains and their genotypic profiles: Patient and environmental bacterial isolates, identified as Acinetobacter spp., were tested for antimicrobial susceptibility at the NHO-MMC. Antimicrobial resistance was interpreted according to Clinical and Laboratory Standards Institute (M100-S17) guidelines, except for amikacin resistance, which was defined as a minimum inhibitory concentration ≧32 mg/ml (10). All isolates, identified as A. baumannii (11), were assessed by using polymerase chain reaction (PCR) to detect bla OXA-51-like , bla OXA-23 like , bla OXA-40 like , and bla OXA58 like genes and ISAbla1 elements (12, 13) , pulsed-field gel electrophoresis (PFGE) of SmaI-digested genomic DNA (14) , and multilocus sequence typing (MLST) (15) at the Department of Bacteriology II in the NIID.
Analytic epidemiology: Because MDRAB was isolated from respiratory specimens such as sputum and throat swabs, we conducted a matched case-control study, including most cases, to identify risk factors for acquiring respiratory tract MDRAB. Controls were defined as hospitalized patients with no MDRAB positive respiratory cultures at least 3 days post admission to the CCC of the NHO-MMC between June 1, 2011 and April 20, 2012, because there were no patients with cultures positive for drug-sensitive Acinetobacter spp. during that period. The case-to-control ratio was approximately 1:2. Before specimen sampling, each case was matched to a control case with less than a 10-day difference in duration of hospitalization. Epidemiological information including patient characteristics, medical procedures, and antimicrobial therapy was reviewed for cases found 3 months prior to obtaining the first MDRAB positive specimen.
Statistical analyses: Conditional logistic regression analysis was conducted with a P value ＜0.05 being considered significant. All statistical analyses were performed using SAS software (version 9.3; SAS Institute Inc., Cary, NC, USA). Because this epidemiological investigation was conducted according to the Act on Prevention of Infectious Diseases and Medical Care for Patients Suffering Infectious Diseases in Japan, review and approval by the ethics committee were not required.
Control measures: After holding an emergency infection control committee meeting at the NHO-MMC on March 15, 2012, the infection control team (ICT) decided to initiate the following infection control measures from March 16 to April 10: (i) temporary closure of the ER and termination of admission to the CCC for 26 days; (ii) single room accommodations for patients with MDRAB colonization or infection; (iii) adherence to proper hand hygiene before and after patient care, along with strict contact precautions, especially during sputum suctioning; (iv) appointment of dedicated personnel to care for MDRAB patients; (v) intensified education through training and video programs for all health care staff; and (vi) extensive, 3 times daily, environmental disinfection of potentially contaminated medical equipment. Applications of a quaternary ammonium compound, followed by 0.01z sodium hypochlorite, were used for environmental cleaning of the ER and east ward of the 7th floor ward where MDRAB strains were isolated.
RESULTS
Descriptive epidemiology: Nosocomial Outbreak of MDRAB in Japan sputum and throat swab cultures of 10 patients (83z). Of these 10 patients, 9 were receiving ventilator treatment. No additional cases were discovered for approximately 1 month after the detection of the last case (Case No. 15) during the study period. Demographic features were compared between the 10 patients who survived and the 5 who did not. No significant difference was found for groups based on age and sex, age (P ＝ 0.36), sex (P ＝ 0.58), or ratio of infection to colonization (P ＝ 0.24) between the 2 groups. Environmental isolates: Environmental culture results before and after implementation of infection control measures appear in Table 2 . A total of 82 environmental specimens were collected on March 12 and 15, 2012, respectively from the CCC and other areas in the NHO-MMC before implementation of infection control measures. Seventeen of the 82 specimens (21z) were positive for MDRAB before implementation of the infection control measures. The culture positive specimens were obtained from stainless steel sinks, bed rails, locker handles, stethoscopes, mobile medical carts, mobile carts with a suction bottle, and an alarm switch on the pulse oximetry monitor in the CCC.
Only 3 of 153 specimens (2z) were MDRAB positive in the CCC and the other NHO-MMC areas after implementation of the infection control measures on March 19, 22, 26, and April 3. Notably, none of the 56 specimens were positive for MDRAB on April 3. Genotypic profiles of isolates: Twelve isolates from MDRAB cases and 4 environmental isolates (1 from a sink cabinet and stethoscope in the CCC and 1 from a doorknob and sink cabinet in the east ward of the 7th floor) were examined by performing PCR, PFGE, and MLST. Although all isolates were positive for both bla OXA-51-like and bla OXA-23-like genes by PCR, the ISAba1 element was only associated with bla OXA-23-like genes in these isolates. This data suggests that OXA-23-like carbapenemase was probably associated with the carbapenem resistance of these 16 isolates. The PFGE analyses clearly demonstrated that all isolates were clonally related (see Fig. 1 ) (16) . MLST analysis of 1 representative isolate demonstrated that it belonged to ST74.
Analytic epidemiology: Seven MDRAB cases and 11 controls met inclusion criteria for the case-control study (Table 3 ). Of the 11 control patients, 1 strain each of Escherichia coli, Serratia marcescens, and Enterobacter asburiae was isolated from 3 patients. No isolates were detected in the 8 control patients.
The duration between hospital admission and specimen sampling was 6 to 19 days (median 13 days) for the MDRAB cases and 5 to 21 days (median 12 days) for MDRAB controls. Conditional logistic regression analysis revealed that acquisition of respiratory tract MDRAB was significantly associated with hypoalbuminemia (crude odds ratio [OR] ＝ 9.4; 95z confidence interval [CI] 1.3-∞; P ＝ 0.03) and carbapenem administration (crude odds ratio [OR] ＝ 9.2; 95zCI 1.1-∞; P ＝ 0.04). Sputum suctioning tended to be associated with MDRAB acquisition (crude OR ＝ 7.1, 95zCI 0.8-∞; P ＝ 0.07).
DISCUSSION
This report describes the clinical and epidemiological features of an outbreak of MDRAB infection and colonization of a Japanese tertiary care hospital occurring primarily in the CCC. Of 15 MDRAB cases, 3 were associated with bloodstream infection and 12 were associated with MDRAB colonization. The median age of the cases was 73 years, and 60z were male. Two of 3 MDRAB cases were fatal. The majority of the MDRAB cases were clustered between February and March 2012. PFGE and MLST data demonstrated a clonal dissemination of MDRAB isolates with a single clone of ST74 among hospital cases. These isolates were also detected in the CCC environment and in the east ward on the 7th floor (Department of Neurosurgery and Oral Surgery) on March 2012.
ST74 belongs to clonal complex 92, known as a worldwide epidemic lineage with supposed potential to spread extensively (17) . A previous report demonstrated that some strains of Acinetobacter spp. can survive environmental desiccation for weeks (1) , suggesting that survival of Acinetobacter spp. on environmental surfaces may be an important source of transmission (18) . In a recent outbreak of MDRAB infection, MDRAB environmental contamination was found on curtains, door handles, mops, and keyboards (2, 3, 18) . Our data collectively supports the hypothesis that MDRAB strains with a single clone of ST74 gradually accumulated in at least the CCC environment during the outbreak period, causing MDRAB infection and colonization among patients primarily hospitalized in the CCC. Discovery of almost identical PFGE band patterns associated with this outbreak suggests that this strain was recently introduced and disseminated within a short period in the NHO-MMC. Due to an inability to trace the source of MDRAB for each case, the cause of MDRAB introduced into the NHO-MMC remains uncertain.
A previous study reported a gradual decrease in the incidence of MDRAB infection and colonization occurred after establishment of multifaceted infection control procedures (19) . Although a ratio of infection to colonization range from 1:3.5 to 1:12 during MDRAB outbreaks has been reported (20, 21) , we found an infection-to-colonization ratio of 1:4 during the outbreak described in this study. This high ratio of infection to colonization may be due to the fact that this outbreak occurred in the CCC. However, this ratio should decrease during implementation of long-term infection control measures (19) .
This case-control study demonstrated that carbapenem administration 3 months prior to MDRAB detection was associated with acquisition of respiratory tract MDRAB, a discovery that agrees with findings from previous studies (3, 22, 23) . Although this finding does not indicate that carbapenem use directly induces MDRAB, the ICT of this hospital changed its policy to establish an infectious disease physicians' consultation procedure on antimicrobial usage. In this case-control study, hypoalbuminemia was also associated with acquisition of MDRAB. Because hypoalbuminemia is commonly observed in seriously ill patients, we speculated that hypoalbuminemia might be a confounding factor. Although we considered this fact when selecting the control group, and by adjusting for time-at-risk factors in our case-control study, co-morbid illnesses were not matched in order to avoid potential overmatching due to the small number of cases (24) . The trend between the association of sputum suctioning and MDRAB acquisition may be explained by the presence of cross-contamination by incomplete sputum suctioning among admitted patients with MDRAB strains.
After introduction of the control measures, including a temporary closure of the CCC and ER, the positive rate of MDRAB isolation was about 10 times higher before than after the introduction of the control measures. Consequently, this MDRAB outbreak came to a halt by the end of March 2012. This investigation contains at least 4 limitations. First, the investigation period was insufficient for evaluating the effectiveness of the implemented infection control measures. Previous studies have reported that an MDRAB outbreak ceased temporarily, but was followed a recurrent outbreak (25, 26) . Several months to years of evaluation are needed to evaluate the effectiveness of implemented infection control measures. Second, our case-control study was only evaluated MDRAB respiratory tract acquisition risk factors, while the risk factors for MDRAB acquisition from other body sites were not thoroughly examined. Third, certain risk factors in this case-control study may not have been statistically significant because of small sample size. Fourth, although our case-control study evaluated respiratory tract risk factors for MDRAB acquisition, sample collection for MDRAB isolation from potential sources such as ventilators and bronchoscopes was not performed.
In conclusion, this epidemiological investigation details an MDRAB outbreak that included 3 MDRAB infected cases and 12 MDRAB colonized cases, occurring primarily in the CCC of a Japanese tertiary care hospital between June 2011 and April 2012. Microbiological examination revealed a clonal spread of MDRAB isolates with ST74. After implementation of infection control measures including temporary closure of the ER and CCC, and environmental cleaning, the isolation rate of MDRAB in the hospital setting decreased and no further MDRAB cases were found between March 23 and April 20, 2012. Early detection and containment of MDRAB outbreaks are required in areas such as Japan where MDRAB infection or colonization has not yet become endemic.
